Neglected diseases focus of €3.6 million consortium
17 August 2009
Becky Debens
A new consortium will plough €3.6 million into developing drugs to treat human African trypanosomiasis (sleeping sickness) and Leishmaniasis.
The consortium, whose members include the Drugs for Neglected Diseases initiative (DNDi), Switzerland's University of Bern and the public-private venture...
Please Login to read the full article.
17 August 2009
Becky Debens
The consortium, whose members include the Drugs for Neglected Diseases initiative (DNDi), Switzerland's University of Bern and the public-private venture...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Sanofi and DNDi to tackle nine neglected diseases
- US Capitol Capsule: IOM analysis finds little evidence of vaccine harm, debunks autism link
- Sanofi-Aventis donates $25M to WHO neglected diseases programme
- Pharma companies pledge extended support on neglected tropical diseases
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
